1-3 of 3
James Rowland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML

Available to Purchase
Rithin Nedumannil, Michael Ashby, James Rowland, Jacques A. J. Malherbe, Jared Fairbank, Kelli Gray, Sun Loo, Matthew Wright, John Reynolds, Devendra Hiwase, Paula Marlton, Shaun Fleming, Ashish Bajel, Andrew H. Wei
Journal: Blood
Blood (2025) 146 (13): 1625–1629.
https://doi.org/10.1182/blood.2025028594
Published: 2025
Includes: Supplemental data
Journal Articles

Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis

Free
Betty Gration, Cameron Wellard, Elizabeth Moore, Marianne Tan, Matthew Murphy, Kenneth J C Lim, James Rowland, Nada Hamad, Rajeev Rajagopal, Peter Mollee, Andrew Spencer, Hang Quach, Georgia McCaughan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2385.
https://doi.org/10.1182/blood-2024-201790
Published: 2024
Journal Articles

The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma

Free
James Rowland, MBBS,BPharm, Peter Mollee, FRACP,MBBS,MSc,FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 55.
https://doi.org/10.1182/blood-2020-139194
Published: 2020